Advanced Search
Contact | Corporate | Help

Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 Diabetes

Sponsors:
  • Novartis Pharmaceuticals
Phases:
  • Phase IV
IndicationsAcronym:
  • Type 2 Diabetes
Age Groups:
  • Adult
Gender:
Both
Names:
  • Drug: Vildagliptin (LAF237)
  • Drug: Voglibose
  • Drug: Vildagliptin and Voglibose
Enrollment:
24

Additional information about NCT01309698.


SourceSolution © 2008-2012